Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-01

Clinical Trial Update: Platelet Rich Plasma (PRP) in Total Knee Replacement [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating platelet rich plasma (PRP) in total knee replacement has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (PRP)

Snippet

Sponsor: Exactech | Conditions: Osteoarthritis, Inflammatory Arthritis | Phase 4 | Status: COMPLETED